What are functional gastrointestinal complaints?
Stomach and bowel symptoms cannot always be explained by ulcers, inflammatory bowel disease, celiac disease, or another organic disease. In functional gastrointestinal disorders, multiple mechanisms—such as bowel motility, visceral sensitivity, the gut-brain axis, stress response, microbiota, and the autonomic nervous system—can play a role together.
Therefore, the duration of symptoms, alarm signs such as weight loss or bleeding, medications used, nutrition, bowel movement patterns, stress, and sleep should be addressed together during the evaluation.
What did the 2006 MORA study do?
In the study published in the journal Forschende Komplementärmedizin in 2006, 20 participants with functional, non-organic gastrointestinal complaints were randomized into an active MORA bioresonance or placebo group. There were 10 people in each group.
Researchers compared the frequency and severity of gastrointestinal complaints evaluated by the patients and the physician, stomach pain on palpation, meteorism on percussion, and bowel sounds before and after treatment. In the active group, a significant reduction in the frequency and severity of complaints and stomach pain, as well as an improvement in meteorism, was reported. The changes in the placebo group were more limited.
What is the strength of this study?
Many studies in the bioresonance literature are observational or uncontrolled. The important aspect of this study is that it utilized a randomized and placebo-controlled design. This is valuable in terms of partially attempting to control for session expectation alone or the effect of time.
What are its limitations?
The most significant limitation is that the sample consisted of only 20 individuals. In addition, today functional gastrointestinal disorders are classified in more detail using the Rome criteria, IBS subtypes, and standardized patient-reported outcome scales. Therefore, the 2006 study does not replace current large-scale IBS research; rather, it can be evaluated as a clinical signal for new studies.
With what goals can bioresonance be considered?
If application is considered, the most rational goals may be abdominal bloating, functional abdominal pain, quality of life related to bowel regularity, the stress-gut connection, and monitoring the symptom burden. It is more meaningful to record symptom frequency and severity before treatment and compare them with the same criteria afterward.
In which situations is a standard evaluation required first?
If there is blood in the stool, unexplained weight loss, iron deficiency anemia, prominent symptoms waking the patient at night, persistent vomiting, fever, new-onset symptoms at an older age, or a family history of gastrointestinal cancer/IBD, standard gastroenterological evaluation is required first.
Our approach at our Bodrum clinic
We do not evaluate functional bowel complaints based solely on the results of a single device. Nutrition, medications, bowel movement patterns, sleep, stress, physical activity, and, when necessary, laboratory or gastroenterology evaluations are addressed together. If bioresonance is deemed appropriate, it can be applied as a complementary option by determining measurable symptom goals.
Review the main bioresonance guide →
References
- Nienhaus J, Galle M. Placebo-controlled study of the effects of a standardized MORA bioresonance therapy on functional gastrointestinal complaints. Forsch Komplementmed. 2006;13(1):28-34. PMID: 16582548. PubMed
- Rome Foundation. Disorders of Gut-Brain Interaction classification and clinical approach resources.
For a framework where nutrition, lifestyle, existing diagnoses, and supportive methods are addressed together in functional gastrointestinal complaints, you can review the Functional Medicine guide.
Written and medically reviewed by: Dr. Kerem Çağlayan
Last medical review: September 11, 2026
